Skip to main content
SpringerLink
Log in

Evidence-Based Treatment of Actinic Keratoses in Older Adults

  • Chapter
Advances in Geriatric Dermatology

  • 686 Accesses

Abstract

Actinic keratoses are common in older patient populations and the prevalence increases with age. In this chapter, we review the latest clinical data on actinic keratosis treatment as it relates to older adults, outlining the pros and cons of various therapeutic modalities in this special population.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Marks R, Rennie G, Selwood TS. Malignant transformation of solar keratoses to squamous cell carcinoma. Lancet. 1988;1:795–7.

    Article  CAS  PubMed  Google Scholar 

  2. Rigel DS, Cockerell CJ, Carucci J, Wharton J. Actinic keratosis, basal cell carcinoma and squamous cell carcinoma. In: Bolognia JL, Jorizzo JL, Rapini RP, editors. Bolognia textbook of dermatology. 2nd ed. Spain: Mosby Elsevier; 2008. p. 1645.

    Google Scholar 

  3. Werner R, Sammain A, Erdmann R, Hartmann V, Stockfleth E, Nast A. The natural history of actinic keratosis: a systematic review. Br J Dermatol. 2013;169:502–18.

    Article  CAS  PubMed  Google Scholar 

  4. Salasche SJ. Epidemiology of actinic keratoses and squamous cell carcinoma. J Am Acad Dermatol. 2000;42:4–7.

    Article  CAS  PubMed  Google Scholar 

  5. Ishioka P, Marques SA, Hirai AT, Marques ME, Hirata SH, Yamada S. Prevalence of precancerous skin lesions and non-melanoma skin cancer in Japanese-Brazilians in Bauru, Sao Paulo State, Brazil. Cad Saude Publica. 2009;25:965–71.

    Article  PubMed  Google Scholar 

  6. Feldman SR, Fleischer Jr AB, McConnell RC. Most common dermatologic problems identified by internists, 1990–1994. Arch Intern Med. 1998;158:726–30.

    Article  CAS  PubMed  Google Scholar 

  7. Frost CA, Green AC, Williams GM. The prevalence and determinants of solar keratoses at a subtropical latitude (Queensland, Australia). Br J Dermatol. 1998;139:1033–9.

    Article  CAS  PubMed  Google Scholar 

  8. Vitasa BC, Taylor HR, Strickland PT, Rosenthal FS, West S, Abbey H, et al. Association of nonmelanoma skin cancer and actinic keratosis with cumulative solar ultraviolet exposure in Maryland watermen. Cancer. 1990;65:2811–7.

    Article  CAS  PubMed  Google Scholar 

  9. Ziegler A, Jonason AS, Leffell DJ, Simon JA, Sharma HW, Kimmelman J, et al. Sunburn and p53 in the onset of skin cancer. Nature. 1994;372:773–6.

    Article  CAS  PubMed  Google Scholar 

  10. Thompson SC, Jolley D, Marks R. Reduction of solar keratoses by regular sunscreen use. N Engl J Med. 1993;329:1147–51.

    Article  CAS  PubMed  Google Scholar 

  11. Goldberg LH, Kaplan B, Vergilis-Kalner I, Landau J. Liquid nitrogen: temperature control in the treatment of actinic keratosis. Dermatol Surg. 2010;36:1956–61.

    Article  CAS  PubMed  Google Scholar 

  12. Lubritz RR, Smolewski SA. Cryosurgery cure rate of actinic keratoses. J Am Acad Dermatol. 1982;7:631–2.

    Article  CAS  PubMed  Google Scholar 

  13. Gupta AK, Paquet M, Villanueva E, Brintnell W. Interventions for actinic keratoses. Cochrane Database Syst Rev. 2012;12, Cd004415.

    PubMed  Google Scholar 

  14. Jeffes III EW, Tang EH. Actinic keratosis. Current treatment options. Am J Clin Dermatol. 2000;1:167–79.

    Article  PubMed  Google Scholar 

  15. Thai KE, Fergin P, Freeman M, Vinciullo C, Francis D, Spelman L, et al. A prospective study of the use of cryosurgery for the treatment of actinic keratoses. Int J Dermatol. 2004;43:687–92.

    Article  PubMed  Google Scholar 

  16. Poziomczyk CS, Koche B, Dornelles Mde A, Dornelles SI. Pain evaluation in the cryosurgery of actinic keratoses. An Bras Dermatol. 2011;86:645–50.

    Article  PubMed  Google Scholar 

  17. Eaglstein WH, Weinstein GD, Frost P. Fluorouracil: mechanism of action in human skin and actinic keratoses. I. Effect on DNA synthesis in vivo. Arch Dermatol. 1970;101:132–9.

    Article  CAS  PubMed  Google Scholar 

  18. Weinberg JM. Topical therapy for actinic keratoses: current and evolving therapies. Rev Recent Clin Trials. 2006;1:53–60.

    Article  CAS  PubMed  Google Scholar 

  19. Werschler WP. Considerations for use of Fluorouracil cream 0.5 % for the treatment of actinic keratosis in elderly patients. J Clin Aesthet Dermatol. 2008;1:22–7.

    PubMed Central  PubMed  Google Scholar 

  20. Gupta AK. The management of actinic keratoses in the United States with topical fluorouracil: a pharmacoeconomic evaluation. Cutis. 2002;70:30–6.

    PubMed  Google Scholar 

  21. Stough D, Bucko AD, Vamvakias G, Rafal ES, Davis SA. Fluorouracil cream 0.5 % for actinic keratoses on multiple body sites: an 18-month open-label study. Cutis. 2010;85:267–73.

    PubMed  Google Scholar 

  22. Jorizzo JL, Carney PS, Ko WT, Robins P, Weinkle SH, Werschler WP. Fluorouracil 5 % and 0.5 % creams for the treatment of actinic keratosis: equivalent efficacy with a lower concentration and more convenient dosing schedule. Cutis. 2004;74:18–23.

    PubMed  Google Scholar 

  23. Salzman C. Medication compliance in the elderly. J Clin Psychiatry. 1995;56 Suppl 1:18–22. discussion 3.

    PubMed  Google Scholar 

  24. Kaur RR, Alikhan A, Maibach HI. Comparison of topical 5-fluorouracil formulations in actinic keratosis treatment. J Dermatolog Treat. 2010;21:267–71.

    Article  CAS  PubMed  Google Scholar 

  25. Loven K, Stein L, Furst K, Levy S. Evaluation of the efficacy and tolerability of 0.5 % fluorouracil cream and 5 % fluorouracil cream applied to each side of the face in patients with actinic keratosis. Clin Ther. 2002;24:990–1000.

    Article  CAS  PubMed  Google Scholar 

  26. Hemmi H, Kaisho T, Takeuchi O, Sato S, Sanjo H, Hoshino K, et al. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat Immunol. 2002;3:196–200.

    Article  CAS  PubMed  Google Scholar 

  27. Stanley MA. Imiquimod and the imidazoquinolones: mechanism of action and therapeutic potential. Clin Exp Dermatol. 2002;27:571–7.

    Article  CAS  PubMed  Google Scholar 

  28. Stockfleth E, Meyer T, Benninghoff B, Salasche S, Papadopoulos L, Ulrich C, et al. A randomized, double-blind, vehicle-controlled study to assess 5 % imiquimod cream for the treatment of multiple actinic keratoses. Arch Dermatol. 2002;138:1498–502.

    Article  CAS  PubMed  Google Scholar 

  29. Strohal R, Kerl H, Schuster L. Treatment of actinic keratoses with 5 % topical imiquimod: a multicenter prospective observational study from 93 Austrian office-based dermatologists. J Drugs Dermatol. 2012;11:574–8.

    CAS  PubMed  Google Scholar 

  30. Tanghetti E, Werschler P. Comparison of 5 % 5-fluorouracil cream and 5 % imiquimod cream in the management of actinic keratoses on the face and scalp. J Drugs Dermatol. 2007;6:144–7.

    PubMed  Google Scholar 

  31. Hadley G, Derry S, Moore RA. Imiquimod for actinic keratosis: systematic review and meta-analysis. J Invest Dermatol. 2006;126:1251–5.

    Article  CAS  PubMed  Google Scholar 

  32. Swanson N, Abramovits W, Berman B, Kulp J, Rigel DS, Levy S. Imiquimod 2.5 % and 3.75 % for the treatment of actinic keratoses: results of two placebo-controlled studies of daily application to the face and balding scalp for two 2-week cycles. J Am Acad Dermatol. 2010;62:582–90.

    Article  CAS  PubMed  Google Scholar 

  33. Hanke CW, Swanson N, Bruce S, Berman B, Kulp J, Levy S. Complete clearance is sustained for at least 12 months after treatment of actinic keratoses of the face or balding scalp via daily dosing with imiquimod 3.75 % or 2.5 % cream. J Drugs Dermatol. 2011;10:165–70.

    PubMed  Google Scholar 

  34. Hanke CW, Beer KR, Stockfleth E, Wu J, Rosen T, Levy S. Imiquimod 2.5 % and 3.75 % for the treatment of actinic keratoses: results of two placebo-controlled studies of daily application to the face and balding scalp for two 3-week cycles. J Am Acad Dermatol. 2010;62:573–81.

    Article  CAS  PubMed  Google Scholar 

  35. Rosen RH, Gupta AK, Tyring SK. Dual mechanism of action of ingenol mebutate gel for topical treatment of actinic keratoses: rapid lesion necrosis followed by lesion-specific immune response. J Am Acad Dermatol. 2012;66:486–93.

    Article  CAS  PubMed  Google Scholar 

  36. Lebwohl M, Swanson N, Anderson LL, Melgaard A, Xu Z, Berman B. Ingenol mebutate gel for actinic keratosis. N Engl J Med. 2012;366:1010–9.

    Article  CAS  PubMed  Google Scholar 

  37. Martin G, Swanson N. Clinical findings using ingenol mebutate gel to treat actinic keratoses. J Am Acad Dermatol. 2013;68:S39–48.

    Article  CAS  PubMed  Google Scholar 

  38. Lebwohl M, Shumack S, Gold L, Melgaard A, Larsson T, Tyring SK. Long-term follow-up study of ingenol mebutate gel for the treatment of actinic keratoses. JAMA Dermatol. 2013;149:666–70.

    Article  CAS  PubMed  Google Scholar 

  39. Ericson MB, Wennberg AM, Larko O. Review of photodynamic therapy in actinic keratosis and basal cell carcinoma. Ther Clin Risk Manag. 2008;4:1–9.

    CAS  PubMed Central  PubMed  Google Scholar 

  40. Braathen LR, Szeimies RM, Basset-Seguin N, Bissonnette R, Foley P, Pariser D, et al. Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005. J Am Acad Dermatol. 2007;56:125–43.

    Article  PubMed  Google Scholar 

  41. Jeffes EW, McCullough JL, Weinstein GD, Fergin PE, Nelson JS, Shull TF, et al. Photodynamic therapy of actinic keratosis with topical 5-aminolevulinic acid. A pilot dose-ranging study. Arch Dermatol. 1997;133:727–32.

    Article  CAS  PubMed  Google Scholar 

  42. Tran DT, Salmon R. Field treatment of facial and scalp actinic keratoses with photodynamic therapy: survey of patient perceptions of treatment satisfaction and outcomes. Australas J Dermatol. 2011;52:195–201.

    Article  PubMed  Google Scholar 

  43. Sandberg C, Stenquist B, Rosdahl I, Ros AM, Synnerstad I, Karlsson M, et al. Important factors for pain during photodynamic therapy for actinic keratosis. Acta Derm Venereol. 2006;86:404–8.

    Article  PubMed  Google Scholar 

  44. Serra-Guillen C, Nagore E, Hueso L, Traves V, Messeguer F, Sanmartín O, et al. A randomized pilot comparative study of topical methyl aminolevulinate photodynamic therapy versus imiquimod 5 % versus sequential application of both therapies in immunocompetent patients with actinic keratosis: clinical and histologic outcomes. J Am Acad Dermatol. 2012;66:e131–7.

    Article  CAS  PubMed  Google Scholar 

  45. Alexiades-Armenakas MR, Geronemus RG. Laser-mediated photodynamic therapy of actinic keratoses. Arch Dermatol. 2003;139:1313–20.

    Article  PubMed  Google Scholar 

  46. Alexiades-Armenakas M. Laser-mediated photodynamic therapy. Clin Dermatol. 2006;24:16–25.

    Article  PubMed  Google Scholar 

  47. Patel G, Armstrong A, DB E. Efficacy of photodynamic therapy vs other interventions in randomized clinical trials for the treatment of actinic keratosis: a systematic review and meta-analysis. JAMA Dermatol. 2014;150:1281–8.

    Article  PubMed  Google Scholar 

  48. Gupta A, Paquet M. Network meta-analysis of the outcome ‘participant complete clearance’ in nonimmunosuppressed participants of eight interventions for actinic keratosis: a follow-up on a Cochrane review. Br J Dermatol. 2013;169:250–9.

    Article  CAS  PubMed  Google Scholar 

  49. Martin GM, Stockfleth E. Diclofenac sodium 3 % gel for the management of actinic keratosis: 10+ years of cumulative evidence of efficacy and safety. J Drugs Dermatol. 2012;11:600–8.

    CAS  PubMed  Google Scholar 

  50. Maltusch A, Rowert-Huber J, Matthies C, Lange-Asschenfeldt S, Stockfleth E. Modes of action of diclofenac 3 %/hyaluronic acid 2.5 % in the treatment of actinic keratosis. J Dtsch Dermatol Ges. 2011;9:1011–7.

    PubMed  Google Scholar 

  51. Pirard D, Vereecken P, Melot C, Heenen M. Three percent diclofenac in 2.5 % hyaluronan gel in the treatment of actinic keratoses: a meta-analysis of the recent studies. Arch Dermatol Res. 2005;297:185–9.

    Article  CAS  PubMed  Google Scholar 

  52. Smith SR, Morhenn VB, Piacquadio DJ. Bilateral comparison of the efficacy and tolerability of 3 % diclofenac sodium gel and 5 % 5-fluorouracil cream in the treatment of actinic keratoses of the face and scalp. J Drugs Dermatol. 2006;5:156–9.

    PubMed  Google Scholar 

  53. Heller EH, Shiffman NJ. Synthetic retinoids in dermatology. Can Med Assoc J. 1985;132:1129–36.

    CAS  PubMed Central  PubMed  Google Scholar 

  54. Thorne EG. Long-term clinical experience with a topical retinoid. Br J Dermatol. 1992;127:31–6.

    Article  PubMed  Google Scholar 

  55. Weinstock MA, Bingham SF, Digiovanna JJ, Rizzo AE, Marcolivio K, Hall R, et al. Tretinoin and the prevention of keratinocyte carcinoma (Basal and squamous cell carcinoma of the skin): a veterans affairs randomized chemoprevention trial. J Invest Dermatol. 2012;132:1583–90.

    Article  CAS  PubMed  Google Scholar 

  56. Mukherjee S, Date A, Patravale V, Korting HC, Roeder A, Weindl G. Retinoids in the treatment of skin aging: an overview of clinical efficacy and safety. Clin Interv Aging. 2006;1:327–48.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  57. Kang S, Goldfarb MT, Weiss JS, Metz RD, Hamilton TA, Voorhees JJ, et al. Assessment of adapalene gel for the treatment of actinic keratoses and lentigines: a randomized trial. J Am Acad Dermatol. 2003;49:83–90.

    Article  PubMed  Google Scholar 

  58. Ostertag JU, Quaedvlieg PJ, van der Geer S, Nelemans P, Christianen ME, Neumann MH, et al. A clinical comparison and long-term follow-up of topical 5-fluorouracil versus laser resurfacing in the treatment of widespread actinic keratoses. Lasers Surg Med. 2006;38:731–9.

    Article  PubMed  Google Scholar 

  59. Hantash BM, Stewart DB, Cooper ZA, Rehmus WE, Koch R, Swetter SM. Facial resurfacing for nonmelanoma skin cancer prophylaxis. Arch Dermatol. 2006;142:976–82.

    PubMed  Google Scholar 

  60. Coleman III WP, Yarborough JM, Mandy SH. Dermabrasion for prophylaxis and treatment of actinic keratoses. Dermatol Surg. 1996;22:17–21.

    PubMed  Google Scholar 

  61. Rendon MI, Berson DS, Cohen JL, Roberts WE, Starker I, Wang B. Evidence and considerations in the application of chemical peels in skin disorders and aesthetic resurfacing. J Clin Aesthet Dermatol. 2010;3:32–43.

    PubMed Central  PubMed  Google Scholar 

  62. Monheit GD. The Jessner’s-trichloroacetic acid peel. An enhanced medium-depth chemical peel. Dermatol Clin. 1995;13:277–83.

    Article  CAS  PubMed  Google Scholar 

  63. Lawrence N, Cox SE, Cockerell CJ, Freeman RG, Cruz Jr PD. A comparison of the efficacy and safety of Jessner’s solution and 35 % trichloroacetic acid vs 5 % fluorouracil in the treatment of widespread facial actinic keratoses. Arch Dermatol. 1995;131:176–81.

    Article  CAS  PubMed  Google Scholar 

  64. Witheiler DD, Lawrence N, Cox SE, Cruz C, Cockerell CJ, Freemen RG. Long-term efficacy and safety of Jessner’s solution and 35 % trichloroacetic acid vs 5 % fluorouracil in the treatment of widespread facial actinic keratoses. Dermatol Surg. 1997;23:191–6.

    CAS  PubMed  Google Scholar 

  65. Balkrishnan R, Cayce KA, Kulkarni AS, Orsagh T, Gallagher JR, Richmond D, et al. Predictors of treatment choices and associated outcomes in actinic keratoses: results from a national physician survey study. J Dermatolog Treat. 2006;17:162–6.

    Article  PubMed  Google Scholar 

  66. Tierney EP, Eide MJ, Jacobsen G, Ozog D. Photodynamic therapy for actinic keratoses: survey of patient perceptions of treatment satisfaction and outcomes. J Cosmet Laser Ther. 2008;10:81–6.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. David Getier School of Medicine, 10503 Woodfield Court, Los Angeles, CA, 90077, USA

    Shannon Famenini M.D.

  2. Department of Dermatology, Stanford University School of Medicine, 450 Broadway Street, MC5334, Redwood City, CA, 94063, USA

    Nason Azizi M.D. & Anne Lynn S. Chang M.D. (Assistant Professor)

  3. Albert Einstein College of Medicine, 1300 Morris Park Ave., Bronx, NY, 10461, USA

    Andy Liu B.S.

Authors
  1. Shannon Famenini M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nason Azizi M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Andy Liu B.S.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Anne Lynn S. Chang M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anne Lynn S. Chang M.D. .

Editor information

Editors and Affiliations

  1. Standford University School of Medicine, Redwood City, California, USA

    Anne Lynn S. Chang

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Famenini, S., Azizi, N., Liu, A., Chang, A.L.S. (2015). Evidence-Based Treatment of Actinic Keratoses in Older Adults. In: Chang, A. (eds) Advances in Geriatric Dermatology. Springer, Cham. https://doi.org/10.1007/978-3-319-18380-0_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-18380-0_8

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-18379-4

  • Online ISBN: 978-3-319-18380-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation